AAAAAA
Results:
1-12
|
Results: 12
Authors:
Macejak, DG
Jensen, KL
Pavco, PA
Phipps, KM
Heinz, BA
Colacino, JM
Blatt, LM
Citation: Dg. Macejak et al., Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA, J VIRAL HEP, 8(6), 2001, pp. 400-405
Authors:
Blatt, LM
Mutchnick, MG
Tong, MJ
Klion, FM
Lebovics, E
Freilich, B
Bach, N
Smith, C
Herrera, J
Tobias, H
Conrad, A
Schmid, P
McHutchison, JG
Citation: Lm. Blatt et al., Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States, J VIRAL HEP, 7(3), 2000, pp. 196-202
Authors:
Sandberg, JA
Sproul, CD
Blanchard, KS
Bellon, L
Sweedler, D
Powell, JA
Caputo, FA
Kornbrust, DJ
Parker, VP
Parry, TJ
Blatt, LM
Citation: Ja. Sandberg et al., Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME (TM)) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkey, ANTISENSE N, 10(3), 2000, pp. 153-162
Authors:
McHutchison, JG
Blatt, LM
De Medina, M
Craig, JR
Conrad, A
Schiff, ER
Tong, MJ
Citation: Jg. Mchutchison et al., Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology, J GASTR HEP, 15(8), 2000, pp. 945-951
Authors:
Lee, PA
Blatt, LM
Blanchard, KS
Bouhana, KS
Pavco, PA
Bellon, L
Sandberg, JA
Citation: Pa. Lee et al., Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration inmice, HEPATOLOGY, 32(3), 2000, pp. 640-646
Authors:
Macejak, DG
Jensen, KL
Jamison, SF
Domenico, K
Roberts, EC
Chaudhary, N
von Carlowitz, I
Bellon, L
Tong, MJ
Conrad, A
Pavco, PA
Blatt, LM
Citation: Dg. Macejak et al., Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes, HEPATOLOGY, 31(3), 2000, pp. 769-776
Authors:
Sandberg, JA
Parker, VP
Blanchard, KS
Sweedler, D
Powell, JA
Kachensky, A
Bellon, L
Usman, N
Rossing, T
Borden, E
Blatt, LM
Citation: Ja. Sandberg et al., Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME(TM)) in healthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1462-1469
Authors:
Bonacini, M
Govindarajan, S
Blatt, LM
Schmid, P
Conrad, A
Lindsay, KL
Citation: M. Bonacini et al., Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA, J VIRAL HEP, 6(3), 1999, pp. 203-208
Authors:
McHutchison, JG
Giannelli, G
Nyberg, L
Blatt, LM
Waite, K
Mischkot, P
Pianko, S
Conrad, A
Grint, P
Citation: Jg. Mchutchison et al., A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection, J INTERF CY, 19(11), 1999, pp. 1265-1270
Authors:
Schmid, P
Tong, M
Conrad, A
McHutchison, J
Blatt, LM
Citation: P. Schmid et al., Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT (R) method: results of a 16 year retrospective study, J VIROL MET, 82(2), 1999, pp. 201-206
Authors:
McHutchison, JG
Blatt, LM
Ponnudurai, R
Goodarzi, K
Russell, J
Conrad, A
Citation: Jg. Mchutchison et al., Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection, J MED VIROL, 57(4), 1999, pp. 351-355
Authors:
Bonis, PAL
Tong, MJ
Blatt, LM
Conrad, A
Griffith, JL
Citation: Pal. Bonis et al., A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C, AM J GASTRO, 94(6), 1999, pp. 1605-1612
Risultati:
1-12
|